Table 1 Basic characteristics for patients with DM, without DM and whole

FIB, mg/dL

3.39 ± 0.94

3.34 ± 0.99

3.56 ± 0.80

0.03

Age, year

60.6 ± 10.4

60.07 ± 10.38

62.41 ± 10.23

0.048

Male sex, %

77.1

79.2

70.9

0.081

BMI, kg/m²

24.78 ± 3.25

24.87 ± 3.32

24.65 ± 3.01

0.580

Past PCI or CABG, %

19.2

18.5

21.4

0.525

Past MI, %

15.8

15.3

17.5

0.594

Smoking, %

56.7

58.8

50.5

0.142

Hypertension, %

53.0

52.9

53.4

0.933

Family history, %

40.1

40.3

39.8

0.935

Ejection fraction, (%)

58.4 ± 12.3

58.73 ± 11.78

57.33 ± 13.80

0.371

HGB, g/L

139.3 ± 17.0

139.9 ± 18.0

137.84 ± 13.88

0.230

Platelet, 10³ cells/dL

191.30 ± 66.24

194.21 ± 67.85

186.10 ± 61.83

0.262

Creatinine, mg/dL

71.15 ± 33.76

71.28 ± 36.51

71.06 ± 22.51

0.942

HbA1c, %

6.43 ± 1.40

5.76 ± 0.38

8.36 ± 1.51

< 0.001

FBG, mmol/L

6.38 ± 2.43

5.55 ± 1.38

8.77 ± 3.16

< 0.001

LDL-C, mg/dL

2.22 ± 0.82

2.20 ± 0.82

2.28 ± 0.79

0.410

hsCRP, mg/dL

2.33 ± 2.30

2.22 ± 2.25

2.67 ± 2.42

0.181

CKMB, U/L

37.88 ± 555.93

37.12 ± 54.5

39.34 ± 58.94

0.739

Pro-BNP, pg/mL

837.36 ± 2076.66

805.19 ± 2097.0

970.62 ± 1960.9

0.474

Medication at discharge

 Aspirin, %

100

100

100

a

 Clopidogrel

100

100

100

a

 Statin, %

97.8

98.1

97.1

0.563

 ACEI/ARB, %

92.5

92.5

92.2

0.921

 CCB, %

24.3

24.4

24.3

0.974

 β-blocker

88.6

89.0

87.4

0.662

 ACS type

0.307

 UA, n (%)

230 (55.9)

179 (58.1)

51 (49.5)

 STEMI, n (%)

122 (29.7)

86 (27.9)

36 (35.0)

 NSTEMI, n (%)

59 (14.4)

43 (14.0)

16 (15.5)

 MACE, %

39.2

41.6

32.0

0.087